The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By

Unfors Raysafe AB

Advised the Sixth Swedish National Pension Fund on the sale of Unfors Raysafe AB, a provider of easy-to-use products that help to reduce unnecessary radiation exposure, to Fluke Biomedical Corp., a subsidiary of Danaher Corp. that manufactures biomedical test and simulation products

Thiele Kaolin Company
Advised Thiele Kaolin Company, a miner and processor of kaolin clay, on a leveraged capitalization and repurchase of a 40% stock interest from Stora Enso Oyj

Fidelis SeniorCare Inc. (Michigan Heath Plan)

Advised Fidelis SeniorCare Inc., a healthcare provider focused on the care of the elderly, on the sale of a majority of its SecureCare Michigan health plan to Centene Corporation, a managed care provider focused on the Medicaid space

US Forestlands and Partnership Interest in the South Carolina Real Estate Assets of MeadWestvaco

Provided fairness opinion to the Board of Directors of MeadWestvaco Corporation on the sale of its US forestlands and a partnership stake in its South Carolina Real Estate assets to Plum Creek Timber

Electronics Manufacturing Solutions Segment of CTS Corporation

Advised CTS Corporation on the sale of its Electronics Manufacturing Solutions segment, an electronics contract manufacturing service provider, to Benchmark Electronics

Fresh & Easy (owned by Tesco plc)

Advised Tesco plc, a listed FTSE 100 retailer, on the sale of a substantive part of Fresh & Easy’s operating business to YFE Holdings, Inc, an affiliate of The Yucaipa Companies, LLC

Sinclair Knight Merz

Advised Sinclair Knight Merz, a leading projects firm, with global capability in strategic consulting, engineering and project delivery on its recommended merger with Jacobs Engineering

Futuris Automotive

Advised Elders on the sale of Futuris Automotive, Australia’s largest automotive component manufacturer, to Clearlake Capital, a US based private equity firm

Warner Chilcott, plc

Advised Actavis, Inc., a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, branded and biosimilar products on its acquisition of Warner Chilcott plc

GrainCorp Limited

Advised GrainCorp Limited on the unsolicited takeover offer from Archer Daniels Midland Company, a global agribusiness that converts oilseeds, corn, wheat and cocoa into products for food, animal feed and energy uses

SUPERVALU, Inc.

Advised SUPERVALU, a leading food retailer, on the sale of its New Albertsons, Inc. subsidiary to an investor group led by Cerberus Capital Management L.P. In addition to the sale, Greenhill also advised the Company on a simultaneous equity tender offer by Cerberus for up to a 30% stake in pro forma SUPERVALU

NewPage Corp.
Advised Stora Enso Oyj, a global paper, packaging and wood products producer headquartered in Helsinki, Finland, in connection with the Chapter 11 proceeding of NewPage, the largest North American coated-paper manufacturer

Target Corporation’s REDcard credit card assets

Advised The Toronto-Dominion Bank Group on its acquisition of Target Corporation’s REDcard credit card assets

Guardian Industries

Advised the Special Committee of the Board of Directors of Guardian Industries, one of the world’s leading glass manufacturers, in connection with its recapitalization and sale of a minority stake to Koch Industries

Becker Underwood

Advised Norwest Equity Partners on the sale of its portfolio company Becker Underwood, a global leader in the development and commercialization of yield-improving seed-applied biological products for the Agricultural market, to BASF, the world’s largest chemical company

Performance Coatings division of E. I. DuPont de Nemours and Company

Advised E. I. Du Pont de Nemours and Company, a global diversified chemicals company, on the sale of its Performance Coatings division to an affiliate of The Carlyle Group, a leading private equity firm

Coventry Health Care Inc.

Advised Coventry Health Care Inc., a diversified managed health care company that offers a full portfolio of managed care products serving the commercial group and individual, Medicare Advantage, Medicare Part D and Medicaid markets, on its acquisition by Aetna

WMF Württembergische Metallwarenfabrik AG

Provided fairness opinion to the Executive Management Board of WMF in connection with the voluntary public takeover offer by Finedining Capital GmbH, a holding company in the possession of funds managed by Kohlberg Kravis Roberts & Co. L.P.

Polar Ware Company

Advised Polar Ware Company, a food equipment company with a broad product portfolio including soft-serve ice cream and frozen yogurt machines and food serving equipment and smallwares, on its sale to The Vollrath Company, a manufacturer of foodservice products

Armajaro Trading Limited

Advised Armajaro Trading Limited, a global soft commodity trading house and supply chain manager, on raising mezzanine capital from the International Finance Corporation, a unit of the World Bank

Flow Control Business of Tyco International Ltd.

Provided fairness opinion to the Board of Directors of Pentair, Inc. in connection with its all-stock merger with Tyco Flow Control, a division of Tyco International Ltd. (+Transaction value represents enterprise value of combined entity)

ISTA Pharmaceuticals, Inc.

Advised ISTA Pharmaceuticals, an ophthalmic pharmaceutical company, on its sale to Bausch + Lomb, Inc., a global ophthalmic products company

ISTA Pharmaceuticals, Inc.
Advised ISTA Pharmaceuticals, an ophthalmic pharmaceutical company, on its defense against an unsolicited offer from Valeant Pharmaceuticals and on its review of strategic alternatives

Pension Benefit Guaranty Corporation
Advised the Pension Benefit Guaranty Corporation (“PBGC”) in connection with the Chapter 11 filing of AMR Corporation, the parent company of American Airlines, Inc. and American Eagle Airlines, Inc.

iNova Pharmaceuticals

Advised Archer Capital and Ironbridge Capital on the sale of iNova Pharmaceuticals, a leading pharmaceuticals company that sells and distributes a range of prescription and over-the-counter products in Australia, New Zealand, Asia and Southern Africa, to Valeant Pharmaceuticals